Our study on repeated antibiotic prescribing in patients living with dementia. While we found no association with seizure or other neuropsychiatric disorders, repeated antibiotic courses were associated with an increased risk of all-cause hospitalization. https://t.co/MfxoeSOmok
Happy to share our study on Pneumococcal disease epidemiology on International Journal of Infectious Diseases:
Children and adolescents had an elevated risk of gaining antimicrobial resistance, suggesting more measures to reduce S. pneumoniae infections
https://t.co/x0pvnqkL2q
Our new study is out! We looked at anaemia treatments (ESAs) and fracture risk in CKD patients.
Prolonged ESA use seems linked to a higher risk of osteoporotic fractures. This suggests we need to optimise treatment to balance benefits vs. risk. Full text: https://t.co/h3GtofA46m
Our modified self-controlled case series (https://t.co/ovfmS22Lul) did not identify an increased #ischemic_stroke risk with #PPI_monotherapy. However, co-prescription with #antithrombotics was associated with a higher risk. Careful monitoring is needed for them.
@ChuiCeline
Excited to share our latest study in @TheLancet: long-acting injectable antipsychotics (LAIAs) are more effective than oral and equally safe for older people, except for higher risk of EPS with typical LAIAs, but not with atypical LAIAs. @Esther_CSMPRHKU
https://t.co/xQB0YitlVz
Excited to share our latest study in @LancetRH_WPac : Psychotropic medication consumption increased globally after the onset of the COVID-19 pandemic, with variations in consumption patterns observed across different countries. @Esther_CSMPRHKU
https://t.co/umLRvID1Tl
Our multinational database study in @eClinicalMed
compared antihypertensive prescribing trends in Hong Kong, United Kingdom, Sweden, and Australia, providing evidence on the use of blood pressure-lowering drugs before and after a diagnosis of dementia.
https://t.co/CDKZL0dcQq
Read our paper on 18 Countries and HK Opioid Prescribing Trend from 2001 to 2019. Very big differences between countries and US is going down.
https://t.co/8ky28wjo6C
Duramax, a reinforcement learning framework designed to optimize long-term lipid-modifying therapy for CVD prevention. It helps bridge the gap between AI-driven precision and real-world clinical utility.
https://t.co/oLYZVsrj3a
Our latest longitudinal study on trends in #benzodiazepines and #Z-drug prescribing in Hong Kong has just been published with @ElsevierConnect in @LancetRH_WPac. We found increasing trends from 2014 to 2023, with a notable increase in young adults. @Esther_CSMPRHKU
Our study, the largest conducted to date examining various classes of antihypertensive drugs and dementia risk. We found a lower risk of all-cause dementia with ARBs compared to ACE inhibitors. Hong Kong, UK, Sweden, and Australia data included.
https://t.co/GJajp4h6uK
Our study reveals persistently elevated rates of psychotropic drug prescriptions beyond the initial phase of the pandemic among patients with depression and anxiety in the post-pandemic era. The Lancet Psychiatry https://t.co/YGohE2iZ6H